University of Texas/MD Anderson Cancer Center UT MD Anderson — Houston, Texas

University of Texas/MD Anderson Cancer Center UT MD Anderson is a clinical research site located in Houston, Texas, United States 77030-4009.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

University of Texas/MD Anderson Cancer Center UT MD Anderson has participated in 1 clinical trials.

Therapeutic areas: Chronic Myelogenous Leukemia, Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Texas/MD Anderson Cancer Center UT MD Anderson?

University of Texas/MD Anderson Cancer Center UT MD Anderson has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Texas/MD Anderson Cancer Center UT MD Anderson conducted?

University of Texas/MD Anderson Cancer Center UT MD Anderson has 1 clinical trials on record. Their work covers Chronic Myelogenous Leukemia, Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia.

Is University of Texas/MD Anderson Cancer Center UT MD Anderson accredited by Crixeo Health?

University of Texas/MD Anderson Cancer Center UT MD Anderson has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Texas/MD Anderson Cancer Center UT MD Anderson?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.